Decruyenaere, A., Christine, G., Sylvie, R., Annouschka, L., Seront, E., Everaert, E., . . . Beuselinck, B. (2025). Optimal treatment duration in metastatic renal cell carcinoma patients responding to immune checkpoint inhibitors: Should we treat beyond two years? Medical Journals Sweden.
Chicago Style (17th ed.) CitationDecruyenaere, Alexander, et al. Optimal Treatment Duration in Metastatic Renal Cell Carcinoma Patients Responding to Immune Checkpoint Inhibitors: Should We Treat Beyond Two Years? Medical Journals Sweden, 2025.
MLA (9th ed.) CitationDecruyenaere, Alexander, et al. Optimal Treatment Duration in Metastatic Renal Cell Carcinoma Patients Responding to Immune Checkpoint Inhibitors: Should We Treat Beyond Two Years? Medical Journals Sweden, 2025.
Warning: These citations may not always be 100% accurate.